Ticker
JNJ

Price
150.47
Stock movement down
-1.89 (-1.24%)
Company name
Johnson & Johnson
Exchange
(NYSE
,
Currency
USD
)
Sector
Healthcare >
Drug Manufacturers - General
Market cap
362.13B
Ent value
438.61B
Price/Sales
4.04
Price/Book
5.17
Div yield
3.30%
Div growth
5.83%
Growth years
58
FCF payout
62.54%
Trailing P/E
9.41
Forward P/E
13.79
PEG
1.47
EPS growth
19.62%
1 year return
-5.29%
3 year return
-1.63%
5 year return
1.84%
10 year return
3.35%
Last updated: 2024-12-04

iO Charts is a Seeking Alpha partner

BUSINESS INSIGHT

Segment Revenues ($M)

Loading...
Operations comments

In 21Q1 JNJ COVID-19 Vaccine authorized by U.S. FDA for emergency use

In 21Q1 JNJ Single-Shot COVID-19 Vaccine granted emergency use listing by the World Health Organization

In 21Q1 JNJ Single-Shot COVID-19 Vaccine granted conditional marketing authorization by European Commission

The company has not provided an official guidance for COVID-19 Vaccine revenues and margins for 2021

Geographic Revenues ($M)

Loading...

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

DIVIDENDS

Dividend yield - 5y

Loading...
Dividend yield data
Dividend per share4.96
Dividend yield3.30%
Payout frequencyQuarterly
Maximum yield3.64%
Average yield2.79%
Minimum yield2.36%
Discount to avg yield15.39%
Upside potential18.19%
Yield as % of max yield90.68%

Yield distribution (inverse percentile) - 5y

Loading...
Yield distribution data
Dividend yield3.30%
Current yield distribution4.84%
Yield at 100% (Min)2.36%
Yield at 90%2.51%
Yield at 80%2.56%
Yield at 50% (Median)2.73%
Yield at 20%3.02%
Yield at 10%3.14%
Yield at 0% (Max)3.64%

Dividend per share

Loading...
Dividend per share data
Years of growth58 years
CCC statusDividend Champion
Dividend per share4.96
Payout frequencyQuarterly
Ex-div date26 Nov 2024
EPS (TTM)15.83
EPS (1y forward)10.91
EPS growth (5y)19.62%
EPS growth (5y forward)6.40%

Dividend growth

Loading...
Please create a free account or log in to access this chart
Dividend growth data
JNJS&P500
DGR MR4.20%-0.74%
DGR TTM4.47%7.63%
DGR 3 years5.70%5.24%
DGR 5 years5.83%5.40%
DGR 10 years6.14%7.07%
DGR 15 years6.63%6.12%
Time since last change announced234 days
EPS growth (5y)19.62%
EPS growth (5y forward)6.40%

Payout ratio

Loading...
Please create a free account or log in to access this chart
Payout ratio data
EPS coverageFCF coverage
TTM30.40%62.54%
Average--
Forward45.46%-

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E9.41
Price to OCF15.62
Price to FCF19.36
Price to EBITDA11.94
EV to EBITDA14.46

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales4.04
Price to Book5.17
EV to Sales4.89

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count2.41B
EPS (TTM)15.83
FCF per share (TTM)7.70

Income statement

Loading...
Income statement data
Revenue (TTM)89.66B
Gross profit (TTM)61.33B
Operating income (TTM)22.92B
Net income (TTM)38.48B
EPS (TTM)15.83
EPS (1y forward)10.91

Margins

Loading...
Margins data
Gross margin (TTM)68.40%
Operating margin (TTM)25.56%
Profit margin (TTM)42.91%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash25.47B
Net receivables14.95B
Total current assets57.00B
Goodwill36.62B
Intangible assets34.29B
Property, plant and equipment47.59B
Total assets171.97B
Accounts payable8.17B
Short/Current long term debt33.63B
Total current liabilities48.73B
Total liabilities101.95B
Shareholder's equity70.02B
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)23.19B
Capital expenditures (TTM)4.49B
Free cash flow (TTM)18.70B
Dividends paid (TTM)11.70B

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity54.95%
Return on Assets22.37%
Return on Invested Capital37.12%
Cash Return on Invested Capital18.05%

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open151.29
Daily high151.56
Daily low149.75
Daily Volume9.97M
All-time high186.01
1y analyst estimate171.95
Beta0.53
EPS (TTM)15.83
Dividend per share4.96
Ex-div date26 Nov 2024
Next earnings date21 Jan 2025

Downside potential

Loading...
Downside potential data
JNJS&P500
Current price drop from All-time high-19.11%-
Highest price drop-38.78%-56.47%
Date of highest drop11 Aug 19939 Mar 2009
Avg drop from high-9.69%-11.14%
Avg time to new high20 days12 days
Max time to new high1038 days1805 days

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
JNJ (Johnson & Johnson) company logo
Marketcap
362.13B
Marketcap category
Large-cap
Description
Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. Its MedTech segment provides Interventional Solutions, including electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; and neurovascular care that treats hemorrhagic and ischemic stroke. this segment also offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics, ear, nose, and throat procedures; contact lenses under the ACUVUE Brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
Employees
131900
SEC filings
CEO
Alex Gorsky
Country
USA
City
New Brunswick
Stock type
Common stock
CCC status
Dividend Champion
Dividend Frequency
Quarterly
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...